Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_assertion type Assertion NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_head.
- NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_assertion description "[In addition, geldanamycin (HSP90 inhibitor) and two CHK1 inhibitors (UCN-01 and SB218078) exhibited a significantly stronger synergism with cisplatin in FA-proficient cells when compared to FA-deficient cells, suggesting a contribution of their FA pathway inhibitory activity to cisplatin sensitization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_provenance.
- NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_assertion evidence source_evidence_literature NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_provenance.
- NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_assertion SIO_000772 22537224 NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_provenance.
- NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_assertion wasDerivedFrom befree-2016 NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_provenance.
- NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_assertion wasGeneratedBy ECO_0000203 NP977832.RAbehrRohTTdNL_HWy3AtwhW1Wur3_VDemL06pCXK1qdE130_provenance.